Su1064 Early Viral Kinetics Do Not Predict Treatment Outcome With Sofosbuvir + Ribavirin for 12 or 24 Weeks in HCV Genotype 2/3 Patients in the Valence Trial
2014 ◽
Vol 146
(5)
◽
pp. S-978-S-979
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Vol 148
(2)
◽
pp. 355-366.e1
◽
Keyword(s):
2014 ◽
Vol 60
(1)
◽
pp. S4-S5
◽
Keyword(s):